Ram Mukunda - 01 Apr 2026 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Apr 2026, 16:02:29 UTC
Prior SEC filing
04 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ram Mukunda

Key filing fact

Ram Mukunda filed Form 4 for IGC Pharma, Inc. (IGC) on 06 Apr 2026.

Key facts

  • This page summarizes Ram Mukunda's Form 4 filing for IGC Pharma, Inc. (IGC).
  • 8 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 06 Apr 2026, 16:02.

Change

  • Previous filing in this sequence was filed on 04 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001047575 Primary reporting owner

Mukunda Ram

Relationship
CEO, Director
Address
10224 FALLS ROAD, POTOMAC
Signature
/s/ Ram Mukunda
Signature date
06 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IGC transaction

Common Stock

Options Exercise

Transaction value
Shares
+333,333
Change %
+8.3%
Price
$0.000000*
Shares after
4,326,011
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1
IGC transaction

Common Stock

Options Exercise

Transaction value
Shares
+323,077
Change %
+7.5%
Price
$0.2600*
Shares after
4,649,088
Date
01 Apr 2026
Ownership
Direct
Footnotes
F2
IGC transaction

Common Stock

Options Exercise

Transaction value
Shares
+16,667
Change %
+1.9%
Price
$0.000000*
Shares after
877,419
Date
01 Apr 2026
Ownership
BY SPOUSE
Footnotes
F3
IGC transaction

Common Stock

Options Exercise

Transaction value
Shares
+33,332
Change %
+3.8%
Price
$0.000000*
Shares after
910,751
Date
01 Apr 2026
Ownership
BY SPOUSE
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-333,333
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
333,333
Exercise price
Footnotes
F1, F5
IGC transaction Derivative

Options

Options Exercise

Transaction value
Shares
-323,077
Change %
-32%
Price
$0.000000*
Shares after
676,925
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
323,077
Exercise price
$0.2600
Footnotes
F2
IGC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-16,667
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
BY SPOUSE
Underlying class
Common Stock
Underlying amount
16,667
Exercise price
Footnotes
F3, F5
IGC transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-33,332
Change %
-50%
Price
$0.000000*
Shares after
33,334
Date
01 Apr 2026
Ownership
BY SPOUSE
Underlying class
Common Stock
Underlying amount
33,332
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.

Footnote F2

On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025.

Footnote F3

On June 26, 2025, the Reporting Person's spouse was granted RSUs.

Footnote F4

On February 3, 2026, the Reporting Person's spouse was granted RSUs.

Footnote F5

Each restricted stock unit represents a right to receive one share of IGC common stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .